查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生命科学工具市场规模、份额和趋势分析报告，按技术、产品、最终用途、地区、细分市场预测 2023-2030 年
市场调查报告书
商品编码
1233226

生命科学工具市场规模、份额和趋势分析报告，按技术、产品、最终用途、地区、细分市场预测 2023-2030 年

Life Science Tools Market Size, Share & Trends Analysis Report By Technology (Cell Biology, Proteomics), By Product, By End-use (Government & Academic, Healthcare), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 265 Pages | 商品交期: 2-10个工作天内

价格

生命科学工具市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，全球生命科学工具市场规模预计从 2023 年到 2030 年将以 10.8% 的复合年增长率增长，到 2030 年将达到 3306.9 亿美元。

这种增长归因于政府对生命科学技术的资助增加、对细胞和基因疗法的需求、生物製药的采用增加以及来自市场主要参与者的竞争加剧。

全球 COVID-19 病例激增需要快速诊断以遏制疾病的传播，这在大流行期间增加了对生命科学工具的需求，对市场产生了积极影响。传染病的快速诊断、有效的治疗和预防计划对于 COVID-19 大流行期间的病例管理至关重要。目前，为确认 SARS-CoV-2 感染而开发具有成本效益的接触点检测试剂盒和高效调查方法的竞赛正在推动诊断创新的新领域。在这次大流行期间，美国食品和药物管理局已向多项诊断测试授予紧急使用授权 (EUA)，使它们能够快速且易于使用。例如，2022 年 5 月，美国 FDA 向 Abbott Diagnostics Scarborough, Inc. 的快速体外诊断测试 ID NOW COVID-19 2.0 授予 EUA。此外，还有广泛的非处方 COVID-19 测试，这将进一步促进收入。

此外，生命科学工具行业正在扩大基于政府对研究和技术进步的投资增加。美国国家人类基因组研究所 (NHGRI) 和美国国立卫生研究院 (NIH) 等组织积极资助各种生命科学项目。例如，NIH 已资助 4D 核组计划 2500 万美元，以瞭解核组织的基因调控和细胞表达。此外，美国政府还资助多家生命科学公司用于研发目的。例如，Biomedical Advanced Research and Development Authority（BARDA）计划颁发价值 750,000 美元的奖项，以促进医疗保健领域创新技术的发展。因此，增加政府对技术和生命科学研究的资助预计将在未来几年推动市场。

领先企业还通过提供先进的工具和技术为市场的增长做出贡献。此外，每家公司都在向市场推出新的自动化解决方案，这为市场增长提供了有利可图的机会。例如，2022 年 2 月，Covaris, LLC. 宣布推出 truXTRAC FFPE Total NA Auto 96 Kit，这是一个全自动工作流程，包括所有必要的配件、耗材和试剂。该自动化套件由自适应聚焦声学 (AFA) 技术提供支持，可在 5 小时内对 FFPE（福尔马林固定石蜡包埋）样品进行 RNA 和 DNA 纯化和提取。创新解决方案的推出有望在不久的将来推动市场。

生命科学工具市场报告亮点

  • 从技术来看，2022年细胞生物学技术将占据最大份额。为使用和采用干细胞、CAR T 细胞、TCR T 细胞、NK T 细胞和其他细胞疗法而引入的新技术预计将推动该领域的创收。
  • 分产品来看，2022年细胞培养系统和3D细胞培养领域占比最大。细胞生物学在生命科学行业越来越受欢迎，并为该领域产生的收入做出了重大贡献。
  • 按最终用途划分，医疗保健领域将在 2022 年产生最高收入。诊所、医院和诊断实验室越来越多地采用蛋白质组学和基因组学工作流程来治疗和诊断多种临床表现异常，预计这将推动市场发展。
  • 2022年，北美收入占比最大。在该地区，基因组学、蛋白质组学、肿瘤学和诊断筛查的快速采用有助于区域增长。此外，许多领先的市场参与者继续为该地区的生命科学研究开发先进的工具。
  • 预计亚太地区在预测期内的增长率最高。为了利用未开发的道路和有利可图的机会，全球公司在该地区的投资正在推动该地区的市场。

目录

第一章 调查方法和范围

  • 调查方法
  • 调查假设
  • 信息采购
    • 购买的数据库
    • GVR内部数据库
    • 次要信息
    • 次要信息
    • 初步调查
    • 生命科学工具市场研究的样本量：
      • 主要信息：
      • 初步调查详情
      • 次要数据源：
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 市场模式
    • 核酸製剂市场
    • 细胞生物学市场
      • 3D 细胞培养技术的比较
    • 下一代测序和转染电穿孔市场
    • 技术市场研究
      • 用于技术市场份额评估的 Qfd 建模
    • 最终用途的市场调查
  • 全球市场：复合年增长率计算
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 竞争格局的快照

3. 市场变量、趋势和范围

  • 市场细分和范围
  • 市场趋势和前景
  • 市场系列展望
    • 相关/子公司市场展望
  • 市场动态
    • 市场驱动力分析
      • 增加政府对生命科学技术的资助
      • 细胞生长和基因治疗
      • 对生物製药（生物製剂和生物仿製药）的需求不断增长
      • 生命科学工具的技术进步
      • 基因组学和蛋白质组学技术在精准医学中的应用
    • 市场约束因素分析
      • 某些技术成本高
      • 缺乏熟练的专业人员
    • 市场机会分析
      • 在病毒分析中的用途
      • 战略交易和发展的数量增加
  • 2022 年技术采用和增长前景图（百万美元）
  • COVID-19 大流行对全球生命科学工具市场的影响
    • 对供应链的影响
    • 对生命科学和医疗保健行业的影响
  • 营商环境分析
    • SWOT 分析；按因素（政治和法律、经济、技术）
    • 波特五力分析

第四章技术业务分析

  • 生命科学工具市场：技术波动分析
  • 基因组技术
  • 蛋白质组学技术
  • 细胞生物学技术
  • 其他分析和样品製备技术
  • 实验室用品和技术

第五章产品经营分析

  • 生命科学工具市场：产品差异分析
  • 细胞培养系统和 3D 细胞培养
    • 机器
    • 消耗品
    • 细胞和组织培养服务
  • 液相色谱法 (Lc)
    • 机器
    • 消耗品
    • 服务
  • 质谱 (Ms)
    • 机器
    • 消耗品
    • 服务
  • 新一代测序 (Ngs)
    • 机器
    • 消耗品
    • 服务
  • 聚合酶链反应与定量聚合酶链反应
    • 机器
    • 消耗品
    • 服务
  • 流式细胞仪
    • 机器
    • 消耗品
    • 服务
  • 核磁共振波谱 (Nmr)
    • 机器
    • 消耗品
    • 服务
  • 显微镜和电子显微镜
    • 机器
    • 消耗品
    • 服务
  • 核酸製备（小睡）
    • 机器
    • 消耗品
    • 服务
  • 转染装置和基因传递技术
    • 设备
    • 试剂
  • 克隆和基因组工程
    • 试剂盒、试剂和耗材
    • 服务
  • 核酸微阵列
    • 机器
    • 消耗品
    • 服务
  • 桑格测序
    • 机器
    • 消耗品
    • 服务
  • 其他分离技术
    • 机器
    • 消耗品
    • 服务
  • 其他产品和服务
    • 抗体
    • 一般物品
    • 其他
      • 机器
      • 消耗品
      • 服务

第 6 章最终用途业务分析

  • 生命科学工具市场：最终用途变化分析
  • 政府和学术界
  • 生物製药公司
  • 卫生保健
  • 工业应用
  • 其他

7. 生命科学工具市场：按产品、技术和最终用途分类的区域估计和趋势分析

  • 北美
    • SWOT分析：
    • 美国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
    • 加拿大
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
  • 欧洲
    • SWOT分析：
    • 德国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
    • 英国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 赎回场景
    • 法国
      • 主要国家动态
      • 竞争情景
      • 市场情景
    • 意大利
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
    • 西班牙
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 2020年西班牙批准的生物技术研发项目
    • 瑞士
      • 竞争情景
      • 併购与合作，2020-2022
    • 丹麦
      • 主要国家动态
      • 投资丹麦东部当前和未来的生物技术公司
      • 监管框架
    • 挪威
      • 主要国家动态
      • 基于 2021 年收入的顶级生物技术公司
      • 监管框架
    • 瑞典
      • 主要国家动态
      • 市场概况
      • 癌症患病率
      • 监管框架
  • 亚太地区
    • SWOT分析：
    • 日本
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
    • 中国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
    • 印度
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
    • 韩国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 技术集群个性化医疗公共研发项目趋势
      • 监管框架
      • 赎回场景
    • 澳大利亚
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 赎回场景
    • 新加坡
      • 主要国家动态
      • 竞争情景
      • 赎回场景
    • 泰国
      • 主要国家动态
      • 泰国主要疾病流行情况
      • 监管框架
      • 赎回场景
  • 拉丁美洲
    • SWOT分析：
    • 阿根廷
      • 主要国家动态
      • 市场情景
      • 监管场景
      • 赎回场景
    • 巴西
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
    • 墨西哥
      • 主要国家动态
      • 竞争情景
      • 市场情景
  • 中东和非洲
    • SWOT分析：
    • 南非
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 赎回场景
      • 监管框架
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
    • 沙特阿拉伯
      • 主要国家动态
      • 竞争情景
      • 市场情景
      • 监管框架
      • 赎回场景
    • 科威特
      • 主要国家动态
      • 竞争情景
      • 科威特医疗保健行业的主要发展
      • 监管框架

第八章竞争格局

  • 公司分类
  • 公司市场定位
  • 2022 年公司市场份额分析
  • 企业热图分析
  • 战略规划
  • 公司简介/名单
    • Thermo Fisher Scientific Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Danaher Corporation
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Illumina, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Merck Kgaa
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • BD
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Qiagen
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Bio-Rad Laboratories Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Agilent Technologies, Inc.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Hitachi, Ltd.
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • F. Hoffmann-La Roche Ltd
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Bruker
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Oxford Instruments Plc
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Zeiss International
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
    • Shimadzu Corporation
      • Overview
      • Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 产品对标
      • 战略举措
Product Code: GVR-4-68038-505-2

Life Science Tools Market Growth & Trends:

The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the '4D Nucleome Program', which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Key players are also contributing to the growth of the market by providing advanced tools and techniques. Furthermore, companies are introducing new automated solutions in the market, which, in turn, provide lucrative opportunities for market growth. For instance, in February 2022, Covaris, LLC. announced the launch of truXTRAC FFPE Total NA Auto 96 Kit, a fully automated workflow comprising all necessary accessories, consumables, and reagents. This automated kit is powered by Adaptive Focused Acoustics (AFA) technology that allows both purification and extraction of RNA & DNA for FFPE (formalin fixed paraffin embedded) samples in 5 hours. The introduction of innovative solutions is expected to drive the market in the near future.

Life Science Tools Market Report Highlights:

  • By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment
  • By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment
  • By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market
  • North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region
  • Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Secondary Sources
    • 1.3.5 Primary Research
    • 1.3.6 Sample Size For The Study On Life Science Tools Market:
      • 1.3.6.1 Primary Sources:
      • 1.3.6.2 Details Of Primary Research
      • 1.3.6.3 Secondary Data Sources:
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Market Model
    • 1.6.1 Nucleic Acid Preparation Market
    • 1.6.2 Cell Biology Market
      • 1.6.2.1 Comparison Of 3d Cell Culture Techniques
    • 1.6.3 Next-Generation Sequencing & Transfection Electroporation Market
    • 1.6.4 Market Study, By Technology
      • 1.6.4.1 Qfd Modeling For Market Share Assessment Of Technologies
    • 1.6.5 Market Study, By End Use
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Objectives
    • 1.8.1 Objective 1:
    • 1.8.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, And Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Trends & Outlook
  • 3.3 Market Lineage Outlook
    • 3.3.1 Related/Ancillary Market Outlook
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increased Government Funding For Life Science Technologies
      • 3.4.1.2 Growth Of Cell And Gene Therapies
      • 3.4.1.3 Rise In The Demand For Biopharmaceuticals (Biologics & Biosimilars)
      • 3.4.1.4 Technological Advancements In Life Science Tools
      • 3.4.1.5 Applications Of Genomic And Proteomic Technologies For Precision Medicine
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 High Cost For Some Technologies
      • 3.4.2.2 Dearth Of Skilled Professionals
    • 3.4.3 Market Opportunity Analysis
      • 3.4.3.1 Utility In Viral Analysis
      • 3.4.3.2 Rise In The Number Of Strategic Deals & Developments
  • 3.5 Penetration And Growth Prospect Mapping For Technology, 2022 (USD Million)
  • 3.6 Impact Of Covid-19 Pandemic On Global Life Science Tools Market
    • 3.6.1 Impact On The Supply Chain
    • 3.6.2 Impact On Life Sciences & Healthcare Industry
  • 3.7 Business Environment Analysis
    • 3.7.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
    • 3.7.2 Porter's Five Forces Analysis

Chapter 4 Technology Business Analysis

  • 4.1 Life Science Tools Market: Technology Movement Analysis
  • 4.2 Genomic Technology
    • 4.2.1 Genomic Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.3 Proteomics Technology
    • 4.3.1 Proteomics Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.4 Cell Biology Technology
    • 4.4.1 Cell Biology Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.5 Other Analytical & Sample Preparation Technology
    • 4.5.1 Other Analytical & Sample Preparation Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)
  • 4.6 Lab Supplies & Technologies
    • 4.6.1 Lab Supplies & Technology Market Estimates And Forecast, 2018 - 2030 (USD Billion)

Chapter 5 Product Business Analysis

  • 5.1 Life Science Tools Market: Product Movement Analysis
  • 5.2 Cell Culture Systems & 3d Cell Culture
    • 5.2.1 Life Science Tools Market For Cell Culture Systems & 3d Cell Culture, 2018 - 2030 (USD Million)
    • 5.2.2 Instruments
    • 5.2.3 Consumables
    • 5.2.4 Cell & Tissue Culture Services
  • 5.3 Liquid Chromatography (Lc)
    • 5.3.1 Life Science Tools Market For Liquid Chromatography, 2018 - 2030 (USD Million)
    • 5.3.2 Instruments
    • 5.3.3 Consumables
    • 5.3.4 Services
  • 5.4 Mass Spectrometry (Ms)
    • 5.4.1 Life Science Tools Market For Mass Spectrometry, 2018 - 2030 (USD Million)
    • 5.4.2 Instruments
    • 5.4.3 Consumables
    • 5.4.4 Services
  • 5.5 Next-Generation Sequencing (Ngs)
    • 5.5.1 Life Science Tools Market Estimates And Forecast For Ngs, 2018 - 2030 (USD Billion)
    • 5.5.2 Instruments
    • 5.5.3 Consumables
    • 5.5.4 Services
  • 5.6 Pcr & Qpcr
    • 5.6.1 Life Science Tools Market Estimates And Forecast For Pcr & Qpcr, 2018 - 2030 (USD Million)
    • 5.6.2 Instruments
    • 5.6.3 Consumables
    • 5.6.4 Services
  • 5.7 Flow Cytometry
    • 5.7.1 Life Science Tools Market For Flow Cytometry, 2018 - 2030 (USD Million)
    • 5.7.2 Instruments
    • 5.7.3 Consumables
    • 5.7.4 Services
  • 5.8 Nuclear Magnetic Resonance Spectroscopy (Nmr)
    • 5.8.1 Life Science Tools Market For Nuclear Magnetic Resonance Spectroscopy, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
    • 5.8.3 Consumables
    • 5.8.4 Services
  • 5.9 Microscopy & Electron Microscopy
    • 5.9.1 Life Science Tools Market For Microscopy & Electron Microscopy, 2018 - 2030 (USD Million)
    • 5.9.2 Instruments
    • 5.9.3 Consumables
    • 5.9.4 Services
  • 5.10 Nucleic Acid Preparation (Nap)
    • 5.10.1 Life Science Tools Market For Nucleic Acid Preparation, 2018 - 2030 (USD Million)
    • 5.10.2 Instruments
    • 5.10.3 Consumables
    • 5.10.4 Services
  • 5.11 Transfection Devices & Gene Delivery Technologies
    • 5.11.1 Life Science Tools Market For Transfection Devices & Gene Delivery Technologies, 2018 - 2030 (USD Million)
    • 5.11.2 Equipment
    • 5.11.3 Reagents
  • 5.12 Cloning & Genome Engineering
    • 5.12.1 Life Science Tools Market For Cloning & Genome Engineering, 2018 - 2030 (USD Million)
    • 5.12.2 Kits, Reagents, And Consumables
    • 5.12.3 Services
  • 5.13 Nucleic Acid Microarray
    • 5.13.1 Life Science Tools Market For Nucleic Acid Microarray, 2018 - 2030 (USD Million)
    • 5.13.2 Instruments
    • 5.13.3 Consumables
    • 5.13.4 Services
  • 5.14 Sanger Sequencing
    • 5.14.1 Life Science Tools Market For Sanger Sequencing, 2018 - 2030 (USD Million)
    • 5.14.2 Instrument
    • 5.14.3 Consumables
    • 5.14.4 Services
  • 5.15 Other Separation Technologies
    • 5.15.1 Life Science Tools Market For Other Separation Technologies, 2018 - 2030 (USD Million)
    • 5.15.2 Instrument
    • 5.15.3 Consumables
    • 5.15.4 Services
  • 5.16 Other Products & Services
    • 5.16.1 Life Science Tools Market For Other Products & Services, 2018 - 2030 (USD Million)
    • 5.16.2 Antibodies
    • 5.16.3 General Supplies
    • 5.16.4 Others
      • 5.16.4.1 Life Science Tools Market For Others, 2018 - 2030 (USD Million)
      • 5.16.4.2 Instruments
      • 5.16.4.3 Consumables
      • 5.16.4.4 Services

Chapter 6 End-Use Business Analysis

  • 6.1 Life Science Tools Market: End-Use Movement Analysis
  • 6.2 Government & Academic
    • 6.2.1 Life Science Tools Market For Government & Academic End Use, 2018 - 2030 (USD Billion)
  • 6.3 Biopharmaceutical Company
    • 6.3.1 Life Science Tools Market For Biopharmaceutical Companies, 2018 - 2030 (USD Billion)
  • 6.4 Healthcare
    • 6.4.1 Life Science Tools Market For Health Care End Use, 2018 - 2030 (USD Billion)
  • 6.5 Industrial Applications
    • 6.5.1 Life Science Tools Market For Industry End Use, 2018 - 2030 (USD Billion)
  • 6.6 Other
    • 6.6.1 Life Science Tools Market For Other End Use, 2018 - 2030 (USD Billion)

Chapter 7 Life Sciences Tools Market: Regional Estimates And Trend Analysis, By Product, Technology, & End-Use

  • 7.1 North America
    • 7.1.1 Swot Analysis:
      • 7.1.1.1 North America Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.1.2 U.S.
      • 7.1.2.1 Key Country Dynamics
      • 7.1.2.2 Competitive Scenario
      • 7.1.2.3 Market Scenario
      • 7.1.2.4 Regulatory Framework
      • 7.1.2.5 Reimbursement Scenario
      • 7.1.2.6 U.S. Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.1.3 Canada
      • 7.1.3.1 Key Country Dynamics
      • 7.1.3.2 Competitive Scenario
      • 7.1.3.3 Market Scenario
      • 7.1.3.4 Regulatory Framework
      • 7.1.3.5 Reimbursement Scenario
      • 7.1.3.6 Canada Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.2 Europe
    • 7.2.1 Swot Analysis:
      • 7.2.1.1 Europe Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2 Germany
      • 7.2.2.1 Key Country Dynamics
      • 7.2.2.2 Competitive Scenario
      • 7.2.2.3 Market Scenario
      • 7.2.2.4 Regulatory Framework
      • 7.2.2.5 Reimbursement Scenario
      • 7.2.2.6 Germany Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.3 UK
      • 7.2.3.1 Key Country Dynamics
      • 7.2.3.2 Competitive Scenario
      • 7.2.3.3 Market Scenario
      • 7.2.3.4 Reimbursement Scenario
      • 7.2.3.5 UK Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4 France
      • 7.2.4.1 Key Country Dynamics
      • 7.2.4.2 Competitive Scenario
      • 7.2.4.3 Market Scenario
      • 7.2.4.4 France Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.5 Italy
      • 7.2.5.1 Key Country Dynamics
      • 7.2.5.2 Competitive Scenario
      • 7.2.5.3 Market Scenario
      • 7.2.5.4 Regulatory Framework
      • 7.2.5.5 Italy Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.6 Spain
      • 7.2.6.1 Key Country Dynamics
      • 7.2.6.2 Competitive Scenario
      • 7.2.6.3 Market Scenario
      • 7.2.6.4 Biotechnology R&D Projects Approved In Spain In 2020
      • 7.2.6.5 Spain Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.7 Switzerland
      • 7.2.7.1 Competitive Scenario
      • 7.2.7.2 M&A And Collaborations, 2020-2022
      • 7.2.7.3 Switzerland Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.8 Denmark
      • 7.2.8.1 Key Country Dynamics
      • 7.2.8.2 Current And Upcoming Biotech Companies Investments In Eastern Denmark
      • 7.2.8.3 Regulatory Framework
      • 7.2.8.4 Denmark Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.9 Norway
      • 7.2.9.1 Key Country Dynamics
      • 7.2.9.2 Top Biotechnology Companies, Based On Revenue As Of 2021
      • 7.2.9.3 Regulatory Framework
      • 7.2.9.4 Norway Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.10 Sweden
      • 7.2.10.1 Key Country Dynamics
      • 7.2.10.2 Market Overview
      • 7.2.10.3 Cancer Prevalance
      • 7.2.10.4 Regulatory Framework
      • 7.2.10.5 Sweden Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.3 Asia Pacific
    • 7.3.1 Swot Analysis:
      • 7.3.1.1 Asia Pacific Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2 Japan
      • 7.3.2.1 Key Country Dynamics
      • 7.3.2.2 Competitive Scenario
      • 7.3.2.3 Market Scenario
      • 7.3.2.4 Regulatory Framework
      • 7.3.2.5 Reimbursement Scenario
      • 7.3.2.6 Japan Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3 China
      • 7.3.3.1 Key Country Dynamics
      • 7.3.3.2 Competitive Scenario
      • 7.3.3.3 Market Scenario
      • 7.3.3.4 Regulatory Framework
      • 7.3.3.5 Reimbursement Scenario
      • 7.3.3.6 China Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4 India
      • 7.3.4.1 Key Country Dynamics
      • 7.3.4.2 Competitive Scenario
      • 7.3.4.3 Market Scenario
      • 7.3.4.4 Regulatory Framework
      • 7.3.4.5 India Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.5 South Korea
      • 7.3.5.1 Key Country Dynamics
      • 7.3.5.2 Competitive Scenario
      • 7.3.5.3 Market Scenario
      • 7.3.5.4 Trend Of Public R&D Projects For Personalized Medicine By Technology Clusters
      • 7.3.5.5 Regulatory Framework
      • 7.3.5.6 Reimbursement Scenario
      • 7.3.5.7 South Korea Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.6 Australia
      • 7.3.6.1 Key Country Dynamics
      • 7.3.6.2 Competitive Scenario
      • 7.3.6.3 Market Scenario
      • 7.3.6.4 Reimbursement Scenario
      • 7.3.6.5 Australia Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.7 Singapore
      • 7.3.7.1 Key Country Dynamics
      • 7.3.7.2 Competitive Scenario
      • 7.3.7.3 Reimbursement Scenario
      • 7.3.7.4 Singapore Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.8 Thailand
      • 7.3.8.1 Key Country Dynamics
      • 7.3.8.2 Thailand Key Disease Prevalence
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Reimbursement Scenario
      • 7.3.8.5 Thailand Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.4 Latin America
    • 7.4.1 Swot Analysis:
      • 7.4.1.1 Latin America Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2 Argentina
      • 7.4.2.1 Key Country Dynamics
      • 7.4.2.2 Market Scenario
      • 7.4.2.3 Regulatory Scenario
      • 7.4.2.4 Reimbursement Scenario
      • 7.4.2.5 Argentina Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3 Brazil
      • 7.4.3.1 Key Country Dynamics
      • 7.4.3.2 Competitive Scenario
      • 7.4.3.3 Market Scenario
      • 7.4.3.4 Regulatory Framework
      • 7.4.3.5 Brazil Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4 Mexico
      • 7.4.4.1 Key Country Dynamics
      • 7.4.4.2 Competitive Scenario
      • 7.4.4.3 Market Scenario
      • 7.4.4.4 Mexico Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Middle East And Africa
    • 7.5.1 Swot Analysis:
      • 7.5.1.1 MEA Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2 South Africa
      • 7.5.2.1 Key Country Dynamics
      • 7.5.2.2 Competitive Scenario
      • 7.5.2.3 Market Scenario
      • 7.5.2.4 Reimbursement Scenario
      • 7.5.2.5 Regulatory Framework
      • 7.5.2.6 South Africa Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3 UAE
      • 7.5.3.1 Key Country Dynamics
      • 7.5.3.2 Competitive Scenario
      • 7.5.3.3 Market Scenario
      • 7.5.3.4 Regulatory Framework
      • 7.5.3.5 Uae Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4 Saudi Arabia
      • 7.5.4.1 Key Country Dynamics
      • 7.5.4.2 Competitive Scenario
      • 7.5.4.3 Market Scenario
      • 7.5.4.4 Regulatory Framework
      • 7.5.4.5 Reimbursement Scenario
      • 7.5.4.6 Saudi Arabia Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5 Kuwait
      • 7.5.5.1 Key Country Dynamics
      • 7.5.5.2 Competitive Scenario
      • 7.5.5.3 Key Development In Healthcare Sector Of Kuwait
      • 7.5.5.4 Regulatory Framework
      • 7.5.5.5 Kuwait Life Sciences Tools Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Company Categorization
  • 8.2 Company Market Positioning
  • 8.3 Company Market Share Analysis, 2022
  • 8.4 Company Heat Map Analysis
  • 8.5 Strategy Mapping
  • 8.6 Company Profiles/Listing
    • 8.6.1 Thermo Fisher Scientific Inc.
      • 8.6.1.1. Overview
      • 8.6.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Strategic Initiatives
    • 8.6.2 Danaher Corporation
      • 8.6.2.1. Overview
      • 8.6.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Strategic Initiatives
    • 8.6.3 Illumina, Inc.
      • 8.6.3.1. Overview
      • 8.6.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Strategic Initiatives
    • 8.6.4 Merck Kgaa
      • 8.6.4.1. Overview
      • 8.6.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Strategic Initiatives
    • 8.6.5 BD
      • 8.6.5.1. Overview
      • 8.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Strategic Initiatives
    • 8.6.6 Qiagen
      • 8.6.6.1. Overview
      • 8.6.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Strategic Initiatives
    • 8.6.7 Bio-Rad Laboratories Inc.
      • 8.6.7.1. Overview
      • 8.6.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Strategic Initiatives
    • 8.6.8 Agilent Technologies, Inc.
      • 8.6.8.1. Overview
      • 8.6.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.8.3. Product Benchmarking
      • 8.6.8.4. Strategic Initiatives
    • 8.6.9 Hitachi, Ltd.
      • 8.6.9.1. Overview
      • 8.6.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.9.3. Product Benchmarking
      • 8.6.9.4. Strategic Initiatives
    • 8.6.10 F. Hoffmann-La Roche Ltd
      • 8.6.10.1. Overview
      • 8.6.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.10.3. Product Benchmarking
      • 8.6.10.4. Strategic Initiatives
    • 8.6.11 Bruker
      • 8.6.11.1. Overview
      • 8.6.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.11.3. Product Benchmarking
      • 8.6.11.4. Strategic Initiatives
    • 8.6.12 Oxford Instruments Plc
      • 8.6.12.1. Overview
      • 8.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.12.3. Product Benchmarking
      • 8.6.12.4. Strategic Initiatives
    • 8.6.13 Zeiss International
      • 8.6.13.1. Overview
      • 8.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.13.3. Product Benchmarking
      • 8.6.13.4. Strategic Initiatives
    • 8.6.14 Shimadzu Corporation
      • 8.6.14.1. Overview
      • 8.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.6.14.3. Product Benchmarking
      • 8.6.14.4. Strategic Initiatives

List of Tables

  • Table 1 NIH common fund awards for biomedical research
  • Table 2 Business grants for life science and biotech in Canada
  • Table 3 PMDA-approved regenerative medicine, April, 2015-January, 2022
  • Table 4 Top biologic drugs in the U.S.
  • Table 5 Sequencing-related preparation procedures and their use
  • Table 6 Automated nucleic acid extraction systems
  • Table 7 Gene discoveries and its application in personalized treatment for neurologic diseases
  • Table 8 List of FDA approved molecular tests by key players for COVID-19 diagnosis
  • Table 9 Illumina workflows to address COVID-19
  • Table 10 Proteomics techniques: advantages and disadvantages
  • Table 11 Recent launch of automated sample preparation system by key market players
  • Table 12 Manufacturers & suppliers operational in the U.S.: laboratory glassware
  • Table 13 Key vendors and models for mass spectrometry instruments
  • Table 14 NGS instruments: comparison
  • Table 15 Cloning related service providers in the U.S.
  • Table 16 Sanger sequencing cleanup kits: types
  • Table 17 Protein lysis buffers for different protein locations
  • Table 18 Total protein extraction reagents for laboratory use
  • Table 19 Applications of proteomics in food and nutrition industry
  • Table 20 Key companies adopting expansion strategy
  • Table 21 Key companies adopting partnership strategy
  • Table 22 Key companies adopting collaboration strategy
  • Table 23 Key companies launching new products/services
  • Table 24 Key companies adopting acquisition strategy
  • Table 25 Key companies adopting other strategies
  • Table 26 List of Secondary Sources
  • Table 27 List of Abbreviations
  • Table 28 Global Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 29 Global Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 30 Global Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 31 Global Life Science Tools Market, by Region, 2018 - 2030 (USD Billion)
  • Table 32 North America Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 33 North America Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 34 North America Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 35 North America Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 36 U.S. Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 37 U.S. Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 38 U.S. Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 39 Canada Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 40 Canada Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 41 Canada Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 42 Europe Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 43 Europe Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 44 Europe Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 45 Europe Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 46 Germany Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 47 Germany Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 48 Germany Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 49 UK Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 50 UK Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 51 UK Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 52 France Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 53 France Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 54 France Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 55 Italy Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 56 Italy Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 57 Italy Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 58 Spain Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 59 Spain Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 60 Spain Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 61 Denmark Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 62 Denmark Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 63 Denmark Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 64 Norway Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 65 Norway Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 66 Norway Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 69 Sweden Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 74 China Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 75 China Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 76 China Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 77 Japan Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 78 Japan Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 79 Japan Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 80 India Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 81 India Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 82 India Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 83 South Korea Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 84 South Korea Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 85 South Korea Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 86 Australia Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 87 Australia Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 88 Australia Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 89 Thailand Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 90 Thailand Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 91 Thailand Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 92 Latin America Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 93 Latin America Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 94 Latin America Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 95 Latin America Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 96 Brazil Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 97 Brazil Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 98 Brazil Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 99 Mexico Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 100 Mexico Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 101 Mexico Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 102 Argentina Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 103 Argentina Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 104 Argentina Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 105 Middle East and Africa Life Science Tools Market, by Country, 2018 - 2030 (USD Billion)
  • Table 106 Middle East and Africa Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 107 Middle East and Africa Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 108 Middle East and Africa Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 109 South Africa Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 110 South Africa Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 111 South Africa Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 115 UAE Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 116 UAE Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 117 UAE Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)
  • Table 118 Kuwait Life Science Tools Market, by Technology, 2018 - 2030 (USD Billion)
  • Table 119 Kuwait Life Science Tools Market, by Product, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait Life Science Tools Market, by End-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Executives contacted
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Analysis of individual techniques for global market modeling
  • Fig. 10 Ancillary market analysis
  • Fig. 11 Commodity flow analysis modeling for nucleic acid preparation market
  • Fig. 12 Key products
  • Fig. 13 Comparison of 3D cell culture techniques
  • Fig. 14 Technology offerings of key players in 3D cell culture market
  • Fig. 15 Next-generation sequencing market: penetration of key players
  • Fig. 16 Transfection electroporation market: penetration of key players
  • Fig. 17 QFD modeling for market share assessment of technologies
  • Fig. 18 Commodity flow analysis modeling for end users
  • Fig. 19 Penetration of key players in the academic/government end-use segment
  • Fig. 20 End-use specific revenues generated by Agilent Technologies
  • Fig. 21 Market snapshot
  • Fig. 22 Segment snapshot
  • Fig. 23 Competitive landscape snapshot
  • Fig. 24 Life science tools market segmentation
  • Fig. 25 Market driver impact
  • Fig. 26 Cell therapies under investigation, by country
  • Fig. 27 Cell therapies under investigation, by type
  • Fig. 28 Clinical trials conducted for gene therapy
  • Fig. 29 Market restraint impact
  • Fig. 30 Penetration and growth prospect mapping
  • Fig. 31 Key macroeconomic challenges associated with the pandemic
  • Fig. 32 Key elements to enhance the supply chain post COVID
  • Fig. 33 Types of COVID-19 tests
  • Fig. 34 Role of NGS to combat COVID-19 outbreak
  • Fig. 35 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 36 Porter's five forces analysis
  • Fig. 37 Life science tools market: technology outlook and key takeaways
  • Fig. 38 Life science tools market: technology movement analysis
  • Fig. 39 Genomic technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Proteomics technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Cell biology technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Other analytical & sample preparation technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Lab supplies & technology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Life science tools market: product outlook and key takeaways
  • Fig. 45 Life science tools market: product movement analysis
  • Fig. 46 Life science tools market for cell culture systems & 3D cell culture, 2018 - 2030 (USD Billion)
  • Fig. 47 Life science tools market estimates and forecast for cell culture systems & 3D cell culture by product, 2018 - 2030 (USD Billion)
  • Fig. 48 Life science tools market for liquid chromatography, 2018 - 2030 (USD Billion)
  • Fig. 49 Life science tools market estimates and forecast for LC, by product, 2018 - 2030 (USD Billion)
  • Fig. 50 Life science tools market for mass spectrometry, 2018 - 2030 (USD Billion)
  • Fig. 51 Life science tools market estimates and forecast for MS, by product, 2018 - 2030 (USD Billion)
  • Fig. 52 Life science tools market estimates and forecast for NGS, 2018 - 2030 (USD Billion)
  • Fig. 53 Life science tools market estimates and forecast for NGS, by product, 2018 - 2030 (USD Billion)
  • Fig. 54 Life science tools market estimates and forecast for PCR & qPCR, 2018 - 2030 (USD Billion)
  • Fig. 55 Life science tools market estimates and forecast for PCR & qPCR, by product, 2018 - 2030 (USD Billion)
  • Fig. 56 Life science tools market for flow cytometry, 2018 - 2030 (USD Billion)
  • Fig. 57 Life science tools market estimates and forecast for flow cytometry, by product, 2018 - 2030 (USD Billion)
  • Fig. 58 Life science tools market for nuclear magnetic resonance spectroscopy, 2018 - 2030 (USD Billion)
  • Fig. 59 Life science tools market estimates and forecast for NMR, by product, 2018 - 2030 (USD Billion)
  • Fig. 60 Life science tools market for microscopy & electron microscopy, 2018 - 2030 (USD Billion)
  • Fig. 61 Life science tools market estimates and forecast for microscopy & electron microscopy, by product, 2018 - 2030 (USD Billion)
  • Fig. 62 Life science tools market for nucleic acid preparation, 2018 - 2030 (USD Billion)
  • Fig. 63 Life science tools market estimates and forecast for NAP, by product, 2018 - 2030 (USD Billion)
  • Fig. 64 Life science tools market for transfection devices & gene delivery technologies, 2018 - 2030 (USD Billion)
  • Fig. 65 Life science tools market estimates and forecast for transfection devices & gene delivery technologies, by product, 2018 - 2030 (USD Billion)
  • Fig. 66 Life science tools market for cloning & genome engineering, 2018 - 2030 (USD Billion)
  • Fig. 67 Life science tools market estimates and forecast for cloning & genome engineering, by product, 2018 - 2030 (USD Billion)
  • Fig. 68 Cloning kits, reagents, and consumables offered by Merck
  • Fig. 69 Life science tools market for nucleic acid microarray, 2018 - 2030 (USD Billion)
  • Fig. 70 Life science tools market for nucleic acid microarray, by product, 2018 - 2030 (USD Billion)
  • Fig. 71 Life science tools market for sanger sequencing, 2018 - 2030 (USD Billion)
  • Fig. 72 Life science tools market for sanger sequencing, by product, 2018 - 2030 (USD Billion)
  • Fig. 73 Life science tools market for other separation technologies, 2018 - 2030 (USD Billion)
  • Fig. 74 Life science tools market for other separation technologies, by product, 2018 - 2030 (USD Billion)
  • Fig. 75 Life science tools market for other products & services, 2018 - 2030 (USD Billion)
  • Fig. 76 Life science tools market estimates and forecast for other products & services, by product, 2018 - 2030 (USD Billion)
  • Fig. 77 Life science tools market for others, 2018 - 2030 (USD Billion)
  • Fig. 78 Life science tools market for others, by product, 2018 - 2030 (USD Billion)
  • Fig. 79 Life science tools market: End-use outlook and key takeaways
  • Fig. 80 Life science tools market: end-use movement analysis
  • Fig. 81 Life science tools market for government & academic end use, 2018 - 2030 (USD Billion)
  • Fig. 82 Life science tools market for biopharmaceutical companies, 2018 - 2030 (USD Billion)
  • Fig. 83 Life science tools market for healthcare end use, 2018 - 2030 (USD Billion)
  • Fig. 84 Life science tools market for industry end use, 2018 - 2030 (USD Billion)
  • Fig. 85 Life science tools market for other end use, 2018 - 2030 (USD Billion)
  • Fig. 86 Regional marketplace: key takeaways
  • Fig. 87 North America: SWOT analysis
  • Fig. 88 North America life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 U.S. life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 Canada life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Europe: SWOT analysis
  • Fig. 94 Europe life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 95 Key country dynamics
  • Fig. 96 Germany life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 97 Key country dynamics
  • Fig. 98 UK life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 99 Key country dynamics
  • Fig. 100 France life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 101 Key country dynamics
  • Fig. 102 Italy life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 103 Key country dynamics
  • Fig. 104 Market scenario
  • Fig. 105 Key country dynamics
  • Fig. 106 Spain life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 107 Switzerland life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 108 Key country dynamics
  • Fig. 109 Current and upcoming biotech companies investments in Eastern Denmark
  • Fig. 110 Regulatory framework
  • Fig. 111 Denmark life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 112 Key country dynamics
  • Fig. 113 Top Biotechnology Companies, Based on revenue as of 2021
  • Fig. 114 Regulatory framework
  • Fig. 115 Norway life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 116 Key country dynamics
  • Fig. 117 Top biotechnology companies, based on revenue as of 2021
  • Fig. 118 Cancer prevalence
  • Fig. 119 Regulatory framework
  • Fig. 120 Sweden life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 121 Europe: SWOT analysis
  • Fig. 122 Asia Pacific life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 123 Key country dynamics
  • Fig. 124 Japan life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 125 Key country dynamics
  • Fig. 126 Regulatory framework
  • Fig. 127 Regulatory scenario
  • Fig. 128 Reimbursement scenario
  • Fig. 129 China life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 130 Key country dynamics
  • Fig. 131 India life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 132 Key country dynamics
  • Fig. 133 Trend of public R&D projects for personalized medicine by technology clusters
  • Fig. 134 Regulatory framework
  • Fig. 135 Reimbursement Scenario
  • Fig. 136 South Korea life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 137 Key country dynamics
  • Fig. 138 Australia life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 139 Singapore life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 140 Key country dynamics
  • Fig. 141 Thailand key disease prevalence
  • Fig. 142 Regulatory framework
  • Fig. 143 Reimbursement scenario
  • Fig. 144 Thailand life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 145 Latin America: SWOT analysis
  • Fig. 146 Latin America life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 147 Key country dynamics
  • Fig. 148 Regulatory scenario
  • Fig. 149 Reimbursement scenario
  • Fig. 150 Argentina life sciences tools estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 151 Key country dynamics
  • Fig. 152 Regulatory framework
  • Fig. 153 Brazil life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 154 Key country dynamics
  • Fig. 155 Mexico life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 156 MEA: SWOT analysis
  • Fig. 157 MEA life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 158 Key country dynamics
  • Fig. 159 Reimbursement scenario
  • Fig. 160 Regulatory framework
  • Fig. 161 South Africa. life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 162 Key country dynamics
  • Fig. 163 Regulatory framework
  • Fig. 164 UAE life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 165 Key country dynamics
  • Fig. 166 Reimbursement scenario
  • Fig. 167 Saudi Arabia life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 168 Key country dynamics
  • Fig. 169 Key development in healthcare sector of Kuwait
  • Fig. 170 Regulatory framework
  • Fig. 171 Kuwait life sciences tools market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 172 Market participant categorization
  • Fig. 173 Life science tools market share analysis, 2022
  • Fig. 174 Strategic framework